Sanofi India, Cipla shares rise on exclusive distribution tie-up
Sanofi India share price, Cipla share price: Shares of pharmaceutical companies Sanofi India and Cipla gained on Wednesday, March 27, after the firms announced an exclusive distribution tie-up for expanding the reach of Sanofi’s Central Nervous System (CNS) portfolio, including its six brands.
Sanofi India share price, Cipla share price: Shares of pharmaceutical companies Sanofi India and Cipla gained on Wednesday, March 27, after the firms announced an exclusive distribution tie-up for expanding the reach of Sanofi’s Central Nervous System (CNS) portfolio, including its six brands.
Sanofi India share price today
Sanofi India shares surged as much as 3.77 per cent to the day's high of Rs 7,999 in early morning deals on the NSE. At 9:41 AM, the counter traded 2.35 per cent higher at Rs 7,889.25 on the NSE.
Cipla share price today
Cipla stock rose as much as 1.61 per cent to the day's high of Rs 1,496 in early morning deals on NSE. At 9:40 AM, the counter traded 0.32 per cent higher at Rs 1,476.9 on the NSE.
According to a regulatory filing released post-market hours on Wednesday, Sanofi India Limited, Sanofi Healthcare India Private Limited, and Cipla Limited announced an exclusive distribution and marketing partnership for the sale and promotion of Sanofi India's Central Nervous System (CNS) product line in India on March 26.
As part of this collaboration, Cipla will handle the distribution of Sanofi India's six CNS brands, including the industry-leading Frisium® brand of anti-epileptic drugs.
According to the joint statement, Sanofi India will continue to own, import, and manufacture its complete range of CNS products across plants in India and internationally, and Cipla will leverage its capabilities and network of marketing and sales professionals, distributors, institutions, and market outreach programmes to expand access to these treatments for patients who need them.
Management Outlook
Rodolfo Hrosz, Managing Director, Sanofi India Limited, said, "Sanofi India’s CNS products are leaders in their respective categories. These well-established brands already improve the lives of many patients across urban centres in the country. Cipla’s wide presence will enable us to expand the reach of this portfolio to healthcare professionals and patients across India."
What does Sanofi do?
Sanofi is a global healthcare company.
What does Cipla do?
Established in 1935, Cipla is a global pharmaceutical company focused on agile and sustainable growth, complex generics, and a deepening portfolio.
Catch the latest stock market updates here. For all other news related to business, politics, tech and auto, visit Zeebiz.com.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Rs 3,500 Monthly SIP for 35 years vs Rs 35,000 Monthly SIP for 16 Years: Which can give you higher corpus in long term? See calculations
Looking for short term investment ideas? Analysts suggest buying these 2 stocks for potential gain; check targets
10:29 AM IST